EGFR inhibitors as first-line therapy in EGFR mutation-positive patients with NSCLC.

Gorden, Kimberly J

EGFR inhibitors as first-line therapy in EGFR mutation-positive patients with NSCLC. [electronic resource] - Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners Jun 2012 - 245-9 p. digital

Publication Type: Journal Article; Review

1477-092X

10.1177/1078155211408373 doi


Animals
Carcinoma, Non-Small-Cell Lung--drug therapy
Clinical Trials as Topic--trends
ErbB Receptors--antagonists & inhibitors
Humans
Lung Neoplasms--drug therapy
Mutation--genetics
Protein Kinase Inhibitors--administration & dosage